Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity-Reference-Cited by-同舟云学术

Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity

Published:2017-07-08 Issue:5 Volume:10 Page:412-420
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Hu S¹,Leblanc AF¹,Gibson AA¹,Hong KW¹,Kim JY¹,Janke LJ²,Li L³,Vasilyeva A³,Finkelstein DB⁴,Sprowl JA⁵,Sweet DH⁶,Schlatter E⁷,Ciarimboli G⁷,Schellens JHM⁸,Baker SD¹,Pabla N¹,Sparreboom A¹

Affiliation:

1. Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy and Comprehensive Cancer Center; Ohio State University; Columbus Ohio USA

2. Department of Pathology; St. Jude Children's Research Hospital; Memphis Tennessee USA

3. Department of Pharmaceutical Sciences; St. Jude Children's Research Hospital; Memphis Tennessee USA

4. Computational Biology; St. Jude Children's Research Hospital; Memphis Tennessee USA

5. Department of Pharmaceutical, Social and Administrative Sciences; School of Pharmacy; D'Youville College; Buffalo New York USA

6. Department of Pharmaceutics, School of Pharmacy; Virginia Commonwealth University; Richmond Virginia USA

7. Medical Clinic D, Experimental Nephrology; Münster Medical Faculty; Münster Germany

8. Division of Molecular Pathology; The Netherlands Cancer Institute; Amsterdam the Netherlands

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cts.12480/fullpdf

Reference42 articles.

1. Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients;Jongh;Br. J. Cancer,2003

2. Cisplatin nephrotoxicity: a review;Yao;Am. J. Med. Sci.,2007

3. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions;Ciarimboli;Am. J. Pathol.,2010

4. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity;Filipski;Clin. Pharmacol. Ther,2009

5. Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase;Franke;Clin. Cancer Res.,2010

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untargeted metabolomics analysis of serum and urine unveils the protective effect of cilastatin on altered metabolic pathways during cisplatin-induced acute kidney injury;Biochemical Pharmacology;2024-09

2. Visualization of intracellular ATP dynamics in the whole kidney under pathophysiological conditions using the kidney slice culture system;2024-05-11

3. Pharmacogenomics of Cancer Chemotherapy: Transporter Polymorphisms and Drug Response;Interdisciplinary Cancer Research;2024

4. Development of a Highly Differentiated Human Primary Proximal Tubule MPS Model (aProximate MPS Flow);Bioengineering;2023-12-21

5. The Protective Effect of Marsdenia tenacissima against Cisplatin-Induced Nephrotoxicity Mediated by Inhibiting Oxidative Stress, Inflammation, and Apoptosis;Molecules;2023-11-14